Pharmaceutical giant Bausch Health Companies Inc. second-quarter results fell short of analyst expectations after the company reported a six per cent drop in revenue.
Revenue fell to US$1.967 billion compared to US$2.1 billion the year prior. The company’s net loss for the quarter was US$145 million compared to US$595 million the year prior. It also cut its full-year forecast.
"The second quarter was a transitional quarter for Bausch Health as we intensified our focus on the Bausch Pharma and Solta businesses," Thomas Appio, the chief executive officer of Bausch Health, said in a press release on Tuesday.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: